What is it about?
Azithromycin slows progression of bronchiolitis obliterans syndrome. Long term survival was not affected by randomization to placebo. Randomized placebo controlled trials in lung transplantation patients is feasible, effective and safe.
Featured Image
Read the Original
This page is a summary of: Long-term effect of azithromycin in bronchiolitis obliterans syndrome, BMJ Open Respiratory Research, October 2019, BMJ,
DOI: 10.1136/bmjresp-2019-000465.
You can read the full text:
Contributors
The following have contributed to this page